These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 110559)

  • 41. Superior function of a bicuspid over a monocuspid patch for reconstruction of a hypoplastic pulmonary root in pigs.
    Sievers HH; Storde U; Rohwedder EB; Lange PE; Onnasch DG; Heintzen PH; Bernhard A
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):580-90. PubMed ID: 8468992
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigen depressant effect of glutaraldehyde for aortic heterografts with a valve, with special reference to a concentration right fit for the preservation of grafts.
    Okamura K; Chiba C; Iriyama T; Itoh T; Maeta H; Ijima H; Mitsui T; Hori M
    Surgery; 1980 Feb; 87(2):170-6. PubMed ID: 6766575
    [No Abstract]   [Full Text] [Related]  

  • 43. The stentless bioprosthesis: surgical challenges and implications for long-term durability.
    Barratt-Boyes BG; Christie GW; Raudkivi PJ
    Eur J Cardiothorac Surg; 1992; 6 Suppl 1():S39-42; discussion S43. PubMed ID: 1389277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of calcification of carbodiimide-processed heart valve tissue by prior blocking of amine groups with monoaldehydes.
    Everaerts F; Gillissen M; Torrianni M; Zilla P; Human P; Hendriks M; Feijen J
    J Heart Valve Dis; 2006 Mar; 15(2):269-77. PubMed ID: 16607911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Construction and evaluation of the property of decellular porcine aortic valve].
    Liu WY; Jin ZX; Gu CH; Zhao DE; Tan HM
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):324-7. PubMed ID: 15854509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The porcine heart valve prosthesis.
    Hancock WD
    Med Instrum; 1977; 11(2):102-3. PubMed ID: 404515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
    Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paravalvular leaks around prosthetic valves implanted in the mitral position: technical refinements of the ovine model.
    Linden BC; Schumacher CW; MacIver RH; Mrachek JP; Bianco RW
    J Heart Valve Dis; 2003 May; 12(3):400-5. PubMed ID: 12803342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experimental and clinical studies on the antigenicity of glutaraldehyde-treated porcine aortic valves].
    Ma ZL
    Zhonghua Yi Xue Za Zhi; 1984 Jan; 64(1):33-5. PubMed ID: 6430491
    [No Abstract]   [Full Text] [Related]  

  • 50. Structural changes in glutaraldehyde-treated porcine heterografts used as substitute cardiac valves. Transmission and scanning electron microscopic observations in 12 patients.
    Ferrans VJ; Spray TL; Billingham ME; Roberts WC
    Am J Cardiol; 1978 Jun; 41(7):1159-84. PubMed ID: 96684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Experimental and clinical studies of grafting of the pulmonary artery and valve].
    Tada S; Tanabe T; Kubo Y; Yokota A; Hashimoto M
    Nihon Kyobu Geka Gakkai Zasshi; 1974 May; 22(5):496-7. PubMed ID: 4474266
    [No Abstract]   [Full Text] [Related]  

  • 52. Heterologous pulmonary valve and prosthetic tube as a substitute for right ventricular outflow.
    Imamura ES; Tatsuno K; Sakakibara S
    Surgery; 1971 May; 69(5):716-21. PubMed ID: 5575498
    [No Abstract]   [Full Text] [Related]  

  • 53. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprosthesis (by Naso et al.).
    Byrne GW; McGregor CG
    Xenotransplantation; 2014; 21(1):11-2. PubMed ID: 24188452
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effect of glutaraldehyde preparations on the properties of biological heart valve prostheses].
    Vrsanský D
    Bratisl Lek Listy; 1991 Jul; 92(7):352-4. PubMed ID: 1913202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tissue glue for sealing plastic valves and bioprostheses in the canine aorta.
    Saggau W; Hatipoglu O; Mittman U; Späth J; Storch HH; Schmitz W; Wurster K
    Scand J Thorac Cardiovasc Surg; 1982; 16(2):129-35. PubMed ID: 7156923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tissue-engineered valves.
    Elkins RC
    Ann Thorac Surg; 2002 Nov; 74(5):1434. PubMed ID: 12440588
    [No Abstract]   [Full Text] [Related]  

  • 57. Influence of viability on canine allograft heart value structure and function.
    Wheatley DJ; McGregor CG
    Cardiovasc Res; 1977 May; 11(3):223-30. PubMed ID: 872162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Young Investigator Committee of the International Xenotransplantation Association-Perspective of advancements in the field in 2023.
    Goerlich CE; Kamberi SS; Ladowski J; Citro A; Connolly M; Fischer K; Salvaris EJ; Singh AK; Wang Y; Stern J; Meier RPH
    Xenotransplantation; 2024; 31(1):e12845. PubMed ID: 38407937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoreaction to xenogenic tissue in cardiac surgery: alpha-Gal and beyond.
    Calafiore AM; Haverich A; Gaudino M; Di Mauro M; Fattouch K; Prapas S; Zilla P
    Eur J Cardiothorac Surg; 2022 Jun; 62(1):. PubMed ID: 35211732
    [No Abstract]   [Full Text] [Related]  

  • 60. Decellularization of xenogenic biologic tissue.
    Dohmen PM; Konertz W
    Ann Thorac Surg; 2008 Jun; 85(6):2163; author reply 2163-4. PubMed ID: 18498860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.